Clinical Trial Update: Efficacy of L-menthol on Breathlessness in Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating inhaled L-menthol for alleviating breathlessness in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• L-menthol (L-menthol)

Snippet

Sponsor: Region Skane | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED